[Evaluation of MYCN amplification in Iranian patients with neuroblastoma by conventional and real time PCR]

Behzad, Poopak; Mohammad, Arzanian; Parvaneh, Vosough; Atoosa, Gharib; Amir, Hamidieh; Mohammad, Ehsani; Masood, Parsania; Abolfazl, Yousefian; Mohammad, Jahangirpour; Kobra, Farahani

Behzad, Poopak; Mohammad, Arzanian; Parvaneh, Vosough; Atoosa, Gharib; Amir, Hamidieh; Mohammad, Ehsani; Masood, Parsania; Abolfazl, Yousefian; Mohammad, Jahangirpour; Kobra, Farahani.

Medical Sciences Journal of Islamic Azad University. 2011; 21 (3): 188-195

Dans Persan | IMEMR | ID: emr-194714

ABSTRACT

ABSTRACT

Background:

There is an international consensus that evaluation of MYCNamplification should be done in all cases of newly diagnosed neuroblastoma. MYCN is the most important prognostic factor for neuroblastoma and determines treatment strategy

Recherche sur Google

Imprimer

XML

Indice: Méditerranée orientale langue: Persan Texte intégral: Med. Sci. J. Islam. Azad Univ. Année: 2011

Documents relatifs à ce sujet

MEDLINE

LILACS

LIS

Recherche sur Google

Imprimer

XML

Indice: Méditerranée orientale langue: Persan Texte intégral: Med. Sci. J. Islam. Azad Univ. Année: 2011